Candida bloodstream infection: A clinical microbiology laboratory perspective

Acta Microbiologica et Immunologica Hungarica

Volumn 61, Issue 3, 2014, Pages 389-398

  Pongrácz, Júlia ^a   Kristóf, Katalin ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

bloodstream infection; Candida spp.; clinical breakpoints

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECHINOCANDIN; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDIASIS; HUMAN; NONHUMAN; REVIEW; SPECIES IDENTIFICATION; CANDIDA; DRUG EFFECTS; FUNGEMIA; GENETICS; HOSPITAL LABORATORY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY;

CANDIDA; CANDIDA GLABRATA;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FUNGEMIA; HUMANS; LABORATORIES, HOSPITAL; MICROBIAL SENSITIVITY TESTS;

EID: 84907567794     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.61.2014.3.11     Document Type: Review

References (45)

1. Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., Edmond, M.B.: Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317 (2004).
2. Sandven, P., Bevanger, L., Digranes, A., Haukland, H.H., Mannsåker, T., Gaustad, P., and the Norwegian Yeast Study Group: Candidemia in Norway (1991 to 2003): Results from a nationwide study. J Clin Microbiol 44(6), 1977 (2006).
3. Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J.M., Zaragoza, R., Montejo, M., Muñoz, P., Ruiz-Camps, I., Cuenca-Estrella, M., Almirante, B.: Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20(4), 245-254 (2014).
4. Arendrup, M.C., Bruun, B., Christensen, J.J., Fuursted, K., Johansen, H.K., Kjaeldgaard, P., Knudsen, J.D., Kristensen, L., Møller, J., Nielsen, L., Rosenvinge, F.S., Røder, B., Schønheyder, H.C., Thomsen, M.K., Truberg, K.: National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 49, 325-334 (2011).
5. Kuhns, M., Rosenberger, A., Bader, O., Reichard, U., Gross, U., Weig, M.: [Incidence of candidaemia following abdominal surgery in German hospitals]. Zentralbl Chir 2013 Nov 15. (in German)
6. Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M.P., Rosso, R., Pallavicini, F.B., Viscoli, C.: Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6, 21 (2006).
7. Pfaller, M.A., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H.U., Quan, S.P., Horn, D.: Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. Diagn Microbiol Infect Dis 74(4), 323-331 (2012).
8. Das, I., Nightingale, P., Patel, M., Jumaa, P.: Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 15, 759-763 (2011).
9. Alexander, B.D., Johnson, M.D., Pfeiffer, C.D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S.A., Perlin, D.S., Pfaller, M.A.: Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56(12), 1724-1732 (2013).
10. Cuenca-Estrella, M., Verweij, P.E., Arendrup, M.C., Arikan-Akdagli, S., Bille, J., Donnelly, J.P., Jensen, H.E., Lass-Flörl, C., Richardson, M.D., Akova, M., Bassetti, M., Calandra, T., Castagnola, E., Cornely, O.A., Garbino, J., Groll, A.H., Herbrecht, R., Hope, W.W., Kullberg, B.J., Lortholary, O., Meersseman, W., Petrikkos, G., Roilides, E., Viscoli, C., Ullmann, A.J.: ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures. Clin Microbiol Infect 18(Suppl. 7), 9-18 (2012).
11. Arendrup, M.C.: Candida and candidaemia. Susceptibility and epidemiology. Dan Med J 60(11), B4698 (2013).
12. Ruhnke, M., Rickerts, V., Cornely, O.A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., Willinger, B., Presterl, E., Rath, P., Ritter, J., Glasmacher, A., Lass-Flörl, C., Groll, A.H.: Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 54(4), 279-310 (2011).
13. Garey, K.W., Rege, M., Pai, M.P., Mingo, D.E., Suda, K.J., Turpin, R.S., Bearden, D.T.: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 43, 25-31 (2006).
14. Morrell, M., Fraser, V.J., Kollef, M.H.: Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob Agents Chemother 49, 3640-3645 (2005).
15. Fortún, J., Martín-Davila, P., Gomez-García de la Pedrosa, E., Pintado, V., Cobo, J., Fresco, G., Meije, Y., Ros, L., Alvarez, M.E., Luengo, J., Agundez, M., Belso, A., Sanchez-Sousa, A., Loza, E., Moreno, S.: Emerging trends in candidemia: A higher incidence but a similar outcome. J Infect 65(1), 64-70 (2012).
16. Pittet, D., Monod, M., Suter, P.M., Frenk, E., Auckenthaler, R.: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220, 751-758 (1994).
17. Posteraro, B., De Pascale, G., Tumbarello, M., Torelli, R., Pennisi, M.A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., Antonelli, M.: Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1-3)-D-glucan assay, Candida score, and colonization index. Crit Care 15, R249 (2011).
18. Wallet, F., Nseir, S., Baumann, L., Herwegh, S., Sendid, B., Boulo, M., Roussel-Delvallez, M., Durocher, A.V., Courcol, R.J.: Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 16, 774-779 (2010).
19. Avni, T., Leibovici, L., Paul, M.: PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 49, 665-670 (2011)
20. Hii, I.M., Chang, H.L., Lin, L.C., Lee, Y.L., Liu, Y.M., Liu, C.E., Chen, C.H., Cheng, Y.R., Chang, C.Y.: Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immun Infect S1684-1182(13)00162-X (2013).
21. Wisplinghoff, H., Ebbersa, J., Geurtza, L., Stefanika, D., Major, Y., Edmond, M.B., Wenzel, R.P., Seifert, H.: Nosocomial bloodstream infections due to Candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43(1), 78-81 (2014).
22. Bassetti, M., Ansaldi, F., Nicolini, L., Malfatto, E., Molinari, M.P., Mussap, M., Rebesco, B., Pallavicini, F.B., Icardi, G., Viscoli, C.: Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 64, 625-629 (2009).
23. Borman, A.M., Petch, R., Linton, C.J., Palmer, M.D., Bridge, P.D., Johnson, E.M.: Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 46(3), 933 (2008).
24. Jensen, R.H., Arendrup, M.C.: Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 49(2), 549-556 (2011).
25. Shin, J.H., Kee, S.J., Shin, M.G., Kim, S.H., Shin, D.H., Lee, S.K., Suh, S.P., Ryang, D.W.: Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40(4), 1244-1248 (2002).
26. Tumbarello, M., Fiori, B., Trecarichi, E.M., Posteraro, P., Losito, A.R., De Luca, A., Sanguinetti, M., Fadda, G., Cauda, R., Posteraro, B.: Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLos One 7(3), e33705 (2012).
27. Tumbarello, M., Posteraro, B., Trecarichi, E.M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., Cauda, R., Sanguinetti, M.: Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45(6), 1843-1850 (2007).
28. Kuhn, D.M., George, T., Chandra, J., Mukherjee, P.K., Ghannoum, M.A.: Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46(6), 1773-1780 (2002).
29. Pfaller, M.A., Castanheira, M., Messer, S.A., Moet, G.J., Jones, R.N.: Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Microbiol Infect Dis 68(3), 278-283 (2010).
30. Krogh-Madsen, M., Arendrup, M.C., Heslet, L., Knudsen, J.D.: Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 42, 938-944 (2006).
31. Forastiero, A., Mesa-Arango, A.C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J.F., Grimalt, J.O., Gomez-Lopez, A., Cuesta, I., Zaragoza, O., Mellado, E.: Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother 57, 4769-4781 (2013).
32. M27-A3 Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-third edition. STANDARD by Clinical and Laboratory Standards Institute, 2008.
33. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST): EUCAST Definitive Document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14, 398-405 (2008).
34. Sanglard, D., Odds, F.C.: Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73-85 (2002).
35. Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J.S., Freire, A., Ramasubramanian, V., Demeyer, I., Nucci, M., Leelarasamee, A., Jacobs, F., Decruyenaere, J., Pittet, D., Ullmann, A.J., Ostrosky-Zeichner, L., Lortholary, O., Koblinger, S., Diekmann-Berndt, H., Cornely, O.A.: Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369, 1519-1527 (2007).
36. Reboli, A.C., Rotstein, C., Pappas, P.G., Chapman, S.W., Kett, D.H., Kumar, D., Betts, R., Wible, M., Goldstein, B.P., Schranz, J., Krause, D.S., Walsh, T.J: Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356, 2472-2482 (2007).
37. Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A.L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., Perfect, J.: Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347, 2020-2029 (2002).
38. Kabbara, N., Lacroix, C., Peffault de Latour, R., Socie, G., Ghannoum, M., Ribaud, P.: Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy. Haematologica 93, 639-640 (2008).
39. Pfeiffer, C.D., Garcia-Effron, G., Zaas, A.K., Perfect, J.R., Perlin, D.S., Alexander, B.D.: Breakthrough invasive candidiasis on micafungin. J Clin Microbiol 48, 2373-2380 (2010).
40. Cornely, O.A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B.J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bille, J., Castagnola, E., Cuenca-Estrella, M., Donnelly, J.P., Groll, A.H., Herbrecht, R., Hope, W.W., Jensen, H.E., Lass-Flörl, C., Petrikkos, G., Richardson, M.D., Roilides, E., Verweij, P.E., Viscoli, C., Ullmann, A.J.: ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7), 19-37 (2012).
41. Pfaller, M.A., Andes, D., Arendrup, M.C., Diekema, D.J., Espinel-Ingroff, A., Alexander, B.D., Brown, S.D., Chaturvedi, V., Fowler, C.L., Ghannoum, M.A., Johnson, E.M., Knapp, C.C., Motyl, M.R., Ostrosky-Zeichner, L., Walsh, T.J.: Clinical breakpoints for voriconazole and Candida species revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis 70, 330-343 (2011).
42. Park, B.J., Arthington-Skaggs, B.A., Hajjeh, R.A., Iqbal, N., Ciblak, M.A., Lee-Yang, W., Hairston, M.D., Phelan, M., Plikaytis, B.D., Sofair, A.N., Harrison, L.H., Fridkin, S.K., Warnock, D.W.: Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother 50, 1287-1292 (2006).
43. Vella, A., De Carolis, E., Vaccaro, L., Posteraro, P., Perlin, D.S., Kostrzewa, M., Posteraro, B., Sanguinetti, M.: Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. J Clin Microbiol 51, 2964-2969 (2013).
44. Vale-Silva, L.A., Pinto, P., Lopes, V., Ramos, H., Pinto, E.: Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp. Eur J Clin Microbiol Infect Dis 31, 941-946 (2012).
45. Pfaller, M.A., Diekema, D.J.: Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 50, 2846-2856 (2012).